Abstract Details

Title Predictors of Long term disability in Pediatric patients with relapse-onset Multiple Sclerosis (MS) on immunomodulatory therapy

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 344

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Areeba Basit, MBBS (Memorial Physician Group) PRESENTER	Dr. Basit has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Amber Salter, PhD (UT Southwestern Medical Center)	Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Soe S. Mar, MD, FAAN (Washington University School of Medicine)	The institution of Dr. Mar has received research support from NIH.

��ɫ��